Reid Hoffman on network society
From Investing in the Future – Greylock's Reid Hoffman and Sarah Guo at CNBC @Work Summit · · CNBC Events
“Well one of the things the way that i think about kind of one of the ongoing decade by decade transformation is how do we become a more network society. Right so it's a network society by us being networked be able to do programs like this remotely it's networked in communications it's networked and work and you know things we've been talking about it's networked in entertainment and i think that ongoing network vacation as a platform for new kinds of apps.”
On , Reid Hoffman, Co-Founder at LinkedIn, spoke about network society during Investing in the Future – Greylock's Reid Hoffman and Sarah Guo at CNBC @Work Summit on CNBC Events.
About Reid Hoffman
Reid Hoffman, co-founder of LinkedIn and a partner at Greylock, has been making public appearances discussing artificial intelligence, cryptocurrency, and healthcare. At the Consensus 2026 conference, Hoffman stated that he bought his first Bitcoin in 2014 and has not sold any since, and he argued that as AI agents outnumber people on the internet, crypto becomes necessary for trust and identity. He said he has returned to crypto with "fresh conviction" and mentioned purchasing a CryptoPunk. At WIRED Health, Hoffman said that if a patient or doctor is not using frontier AI models as a second opinion for serious conditions, he believes they are "bordering on committing malpractice." He also expressed hope that within ten years, every major disease will have target molecules that could make a serious difference. In other appearances, Hoffman discussed the future of work and AI. At the Science x AI Summit, he said that "no one should really be an individual contributor" and that people should instead be "a manager of agents." On the Prof G Markets podcast, he described the transition to an AI-driven economy as "challenging" and noted that it is faster than previous technological shifts. Hoffman also discussed his role as co-founder of Manas AI, an AI-driven drug discovery company, and reiterated his view that AI can expand human capability, a theme he explored in his book "Superagency."